
### [MONDO:0002532](http://purl.obolibrary.org/obo/MONDO_0002532)
**Label:** squamous cell neoplasm

**Subclasses:** [MONDO:0003929](http://purl.obolibrary.org/obo/MONDO_0003929) (micropapillomatosis labialis), [MONDO:0000535](http://purl.obolibrary.org/obo/MONDO_0000535) (tonsil squamous cell carcinoma), [MONDO:0000536](http://purl.obolibrary.org/obo/MONDO_0000536) (pharynx squamous cell carcinoma), [MONDO:0004973](http://purl.obolibrary.org/obo/MONDO_0004973) (adenosquamous lung carcinoma), [MONDO:0001740](http://purl.obolibrary.org/obo/MONDO_0001740) (cornea squamous cell carcinoma), [MONDO:0003486](http://purl.obolibrary.org/obo/MONDO_0003486) (basaloid squamous cell carcinoma), [MONDO:0004212](http://purl.obolibrary.org/obo/MONDO_0004212) (vulvar keratoacanthoma-like carcinoma), [MONDO:0006358](http://purl.obolibrary.org/obo/MONDO_0006358) (parotid gland squamous cell carcinoma), [MONDO:0003487](http://purl.obolibrary.org/obo/MONDO_0003487) (adenoid squamous cell carcinoma), [MONDO:0004213](http://purl.obolibrary.org/obo/MONDO_0004213) (vulvar non-keratinizing squamous cell carcinoma), [MONDO:0004296](http://purl.obolibrary.org/obo/MONDO_0004296) (cervical lymphoepithelioma-like carcinoma), [MONDO:0004693](http://purl.obolibrary.org/obo/MONDO_0004693) (cervix uteri carcinoma in situ), [MONDO:0018907](http://purl.obolibrary.org/obo/MONDO_0018907) (craniopharyngioma), [MONDO:0006198](http://purl.obolibrary.org/obo/MONDO_0006198) (endometrial squamous cell carcinoma), [MONDO:0004052](http://purl.obolibrary.org/obo/MONDO_0004052) (rectal cloacogenic carcinoma), [MONDO:0006230](http://purl.obolibrary.org/obo/MONDO_0006230) (gastric squamous cell carcinoma), [MONDO:0004053](http://purl.obolibrary.org/obo/MONDO_0004053) (Bartholin's gland squamous cell carcinoma), [MONDO:0004292](http://purl.obolibrary.org/obo/MONDO_0004292) (supraglottis verrucous carcinoma), [MONDO:0004293](http://purl.obolibrary.org/obo/MONDO_0004293) (supraglottis squamous cell carcinoma), [MONDO:0006470](http://purl.obolibrary.org/obo/MONDO_0006470) (tonsillar squamous cell carcinoma), [MONDO:0006074](http://purl.obolibrary.org/obo/MONDO_0006074) (adenosquamous carcinoma), [MONDO:0004290](http://purl.obolibrary.org/obo/MONDO_0004290) (subglottis verrucous carcinoma), [MONDO:0004291](http://purl.obolibrary.org/obo/MONDO_0004291) (subglottis squamous cell carcinoma), [MONDO:0001995](http://purl.obolibrary.org/obo/MONDO_0001995) (sphenoid sinus squamous cell carcinoma), [MONDO:0002963](http://purl.obolibrary.org/obo/MONDO_0002963) (acantholytic acanthoma), [MONDO:0004229](http://purl.obolibrary.org/obo/MONDO_0004229) (acantholytic variant squamous cell breast carcinoma), [MONDO:0002962](http://purl.obolibrary.org/obo/MONDO_0002962) (epidermolytic acanthoma), [MONDO:0004469](http://purl.obolibrary.org/obo/MONDO_0004469) (pseudovascular skin squamous cell carcinoma), [MONDO:0003499](http://purl.obolibrary.org/obo/MONDO_0003499) (sarcomatoid squamous cell skin carcinoma), [MONDO:0003497](http://purl.obolibrary.org/obo/MONDO_0003497) (renal pelvis squamous cell carcinoma), [MONDO:0002961](http://purl.obolibrary.org/obo/MONDO_0002961) (large cell acanthoma), [MONDO:0006006](http://purl.obolibrary.org/obo/MONDO_0006006) (verrucous carcinoma), [MONDO:0006401](http://purl.obolibrary.org/obo/MONDO_0006401) (salivary gland adenosquamous carcinoma), [MONDO:0001470](http://purl.obolibrary.org/obo/MONDO_0001470) (anal margin squamous cell carcinoma), [MONDO:0003495](http://purl.obolibrary.org/obo/MONDO_0003495) (ovarian squamous cell neoplasm), [MONDO:0003493](http://purl.obolibrary.org/obo/MONDO_0003493) (thymus squamous cell carcinoma), [MONDO:0003494](http://purl.obolibrary.org/obo/MONDO_0003494) (ovarian squamous cell carcinoma), [MONDO:0003492](http://purl.obolibrary.org/obo/MONDO_0003492) (lacrimal gland squamous cell carcinoma), [MONDO:0003490](http://purl.obolibrary.org/obo/MONDO_0003490) (ampulla of vater squamous cell carcinoma), [MONDO:0006082](http://purl.obolibrary.org/obo/MONDO_0006082) (anal squamous cell carcinoma), [MONDO:0016266](http://purl.obolibrary.org/obo/MONDO_0016266) (squamous cell carcinoma of the corpus uteri), [MONDO:0000514](http://purl.obolibrary.org/obo/MONDO_0000514) (bone squamous cell carcinoma), [MONDO:0003904](http://purl.obolibrary.org/obo/MONDO_0003904) (lung occult squamous cell carcinoma), [MONDO:0002416](http://purl.obolibrary.org/obo/MONDO_0002416) (ethmoid sinus squamous cell carcinoma), [MONDO:0004958](http://purl.obolibrary.org/obo/MONDO_0004958) (oral squamous cell carcinoma), [MONDO:0000993](http://purl.obolibrary.org/obo/MONDO_0000993) (prostate squamous cell carcinoma), [MONDO:0003503](http://purl.obolibrary.org/obo/MONDO_0003503) (fallopian tube squamous cell carcinoma), [MONDO:0003501](http://purl.obolibrary.org/obo/MONDO_0003501) (external ear squamous cell carcinoma), [MONDO:0004316](http://purl.obolibrary.org/obo/MONDO_0004316) (acantholytic squamous cell skin carcinoma), [MONDO:0003502](http://purl.obolibrary.org/obo/MONDO_0003502) (ureter squamous cell carcinoma), [MONDO:0006217](http://purl.obolibrary.org/obo/MONDO_0006217) (gallbladder adenosquamous carcinoma), [MONDO:0003500](http://purl.obolibrary.org/obo/MONDO_0003500) (squamous cell bile duct carcinoma), [MONDO:0004433](http://purl.obolibrary.org/obo/MONDO_0004433) (penis papillary carcinoma), [MONDO:0006059](http://purl.obolibrary.org/obo/MONDO_0006059) (nasal cavity squamous cell carcinoma), [MONDO:0004430](http://purl.obolibrary.org/obo/MONDO_0004430) (penis mixed squamous cell carcinoma), [MONDO:0004552](http://purl.obolibrary.org/obo/MONDO_0004552) (microinvasive cervical squamous cell carcinoma), [MONDO:0006452](http://purl.obolibrary.org/obo/MONDO_0006452) (thymic sarcomatoid carcinoma), [MONDO:0006056](http://purl.obolibrary.org/obo/MONDO_0006056) (squamous cell breast carcinoma), [MONDO:0002093](http://purl.obolibrary.org/obo/MONDO_0002093) (acanthoma (disease)), [MONDO:0004394](http://purl.obolibrary.org/obo/MONDO_0004394) (maxillary sinus squamous cell carcinoma), [MONDO:0006173](http://purl.obolibrary.org/obo/MONDO_0006173) (conjunctival squamous cell carcinoma), [MONDO:0010150](http://purl.obolibrary.org/obo/MONDO_0010150) (head and neck squamous cell carcinoma), [MONDO:0006907](http://purl.obolibrary.org/obo/MONDO_0006907) (pilar sheath acanthoma), [MONDO:0002787](http://purl.obolibrary.org/obo/MONDO_0002787) (adamantinous craniopharyngioma), [MONDO:0002788](http://purl.obolibrary.org/obo/MONDO_0002788) (papillary craniopharyngioma), [MONDO:0006622](http://purl.obolibrary.org/obo/MONDO_0006622) (vulvar seborrheic keratosis), [MONDO:0002301](http://purl.obolibrary.org/obo/MONDO_0002301) (frontal sinus squamous cell carcinoma), [MONDO:0004289](http://purl.obolibrary.org/obo/MONDO_0004289) (glottis verrucous carcinoma), [MONDO:0006621](http://purl.obolibrary.org/obo/MONDO_0006621) (vulvar inverted follicular keratosis), [MONDO:0006467](http://purl.obolibrary.org/obo/MONDO_0006467) (thyroid gland squamous cell carcinoma), [MONDO:0006220](http://purl.obolibrary.org/obo/MONDO_0006220) (gallbladder squamous cell carcinoma), [MONDO:0005097](http://purl.obolibrary.org/obo/MONDO_0005097) (squamous cell lung carcinoma), [MONDO:0005096](http://purl.obolibrary.org/obo/MONDO_0005096) (squamous cell carcinoma), [MONDO:0006060](http://purl.obolibrary.org/obo/MONDO_0006060) (nasopharyngeal squamous cell carcinoma), [MONDO:0002758](http://purl.obolibrary.org/obo/MONDO_0002758) (vulva verrucous carcinoma), [MONDO:0021431](http://purl.obolibrary.org/obo/MONDO_0021431) (squamous cell carcinoma of buccal mucosa), [MONDO:0019077](http://purl.obolibrary.org/obo/MONDO_0019077) (warty dyskeratoma), [MONDO:0002759](http://purl.obolibrary.org/obo/MONDO_0002759) (bladder verrucous carcinoma), [MONDO:0004413](http://purl.obolibrary.org/obo/MONDO_0004413) (cervical non-keratinizing squamous cell carcinoma), [MONDO:0004410](http://purl.obolibrary.org/obo/MONDO_0004410) (sarcomatoid penile squamous cell carcinoma), [MONDO:0006157](http://purl.obolibrary.org/obo/MONDO_0006157) (colorectal adenosquamous carcinoma), [MONDO:0002195](http://purl.obolibrary.org/obo/MONDO_0002195) (vulvar squamous neoplasm), [MONDO:0004131](http://purl.obolibrary.org/obo/MONDO_0004131) (anal Buschke-Lowenstein tumor), [MONDO:0004132](http://purl.obolibrary.org/obo/MONDO_0004132) (anal canal squamous cell carcinoma), [MONDO:0006034](http://purl.obolibrary.org/obo/MONDO_0006034) (gastric adenosquamous carcinoma), [MONDO:0004130](http://purl.obolibrary.org/obo/MONDO_0004130) (anus basaloid carcinoma), [MONDO:0002194](http://purl.obolibrary.org/obo/MONDO_0002194) (vestibular papilloma), [MONDO:0005580](http://purl.obolibrary.org/obo/MONDO_0005580) (esophageal squamous cell carcinoma), [MONDO:0004092](http://purl.obolibrary.org/obo/MONDO_0004092) (thymus basaloid carcinoma), [MONDO:0004093](http://purl.obolibrary.org/obo/MONDO_0004093) (esophageal basaloid carcinoma), [MONDO:0004090](http://purl.obolibrary.org/obo/MONDO_0004090) (vulvar basaloid squamous cell carcinoma), [MONDO:0004091](http://purl.obolibrary.org/obo/MONDO_0004091) (basaloid squamous cell skin carcinoma), [MONDO:0021429](http://purl.obolibrary.org/obo/MONDO_0021429) (squamous cell carcinoma of floor of mouth), [MONDO:0021663](http://purl.obolibrary.org/obo/MONDO_0021663) (sarcomatoid squamous cell carcinoma), [MONDO:0002529](http://purl.obolibrary.org/obo/MONDO_0002529) (skin squamous cell carcinoma), [MONDO:0002765](http://purl.obolibrary.org/obo/MONDO_0002765) (plantar verrucous skin carcinoma), [MONDO:0002764](http://purl.obolibrary.org/obo/MONDO_0002764) (urethra squamous cell carcinoma), [MONDO:0021427](http://purl.obolibrary.org/obo/MONDO_0021427) (squamous cell carcinoma of lip), [MONDO:0000500](http://purl.obolibrary.org/obo/MONDO_0000500) (tongue squamous cell carcinoma), [MONDO:0002766](http://purl.obolibrary.org/obo/MONDO_0002766) (larynx verrucous carcinoma), [MONDO:0002761](http://purl.obolibrary.org/obo/MONDO_0002761) (cervical verrucous carcinoma), [MONDO:0003697](http://purl.obolibrary.org/obo/MONDO_0003697) (non-invasive verrucous carcinoma of the penis), [MONDO:0003698](http://purl.obolibrary.org/obo/MONDO_0003698) (penis verrucous carcinoma), [MONDO:0002760](http://purl.obolibrary.org/obo/MONDO_0002760) (bladder squamous cell carcinoma), [MONDO:0002763](http://purl.obolibrary.org/obo/MONDO_0002763) (urethral verrucous carcinoma), [MONDO:0004542](http://purl.obolibrary.org/obo/MONDO_0004542) (glassy cell variant cervical adenosquamous carcinoma), [MONDO:0006203](http://purl.obolibrary.org/obo/MONDO_0006203) (extrahepatic bile duct squamous cell carcinoma), [MONDO:0002762](http://purl.obolibrary.org/obo/MONDO_0002762) (esophagus verrucous carcinoma), [MONDO:0002086](http://purl.obolibrary.org/obo/MONDO_0002086) (clear cell acanthoma), [MONDO:0004661](http://purl.obolibrary.org/obo/MONDO_0004661) (trachea carcinoma in situ), [MONDO:0006202](http://purl.obolibrary.org/obo/MONDO_0006202) (extrahepatic bile duct adenosquamous carcinoma), [MONDO:0005595](http://purl.obolibrary.org/obo/MONDO_0005595) (laryngeal squamous cell carcinoma), [MONDO:0006165](http://purl.obolibrary.org/obo/MONDO_0006165) (colorectal squamous cell carcinoma), [MONDO:0021538](http://purl.obolibrary.org/obo/MONDO_0021538) (verrucous carcinoma of oral cavity), [MONDO:0018521](http://purl.obolibrary.org/obo/MONDO_0018521) (squamous cell carcinoma of pancreas), [MONDO:0001806](http://purl.obolibrary.org/obo/MONDO_0001806) (vaginal squamous tumor), [MONDO:0003549](http://purl.obolibrary.org/obo/MONDO_0003549) (adenosquamous bile duct carcinoma), [MONDO:0002979](http://purl.obolibrary.org/obo/MONDO_0002979) (papillary squamous carcinoma), [MONDO:0018481](http://purl.obolibrary.org/obo/MONDO_0018481) (undifferentiated carcinoma of esophagus), [MONDO:0003548](http://purl.obolibrary.org/obo/MONDO_0003548) (adenosquamous breast carcinoma), [MONDO:0004239](http://purl.obolibrary.org/obo/MONDO_0004239) (cervical keratinizing squamous cell carcinoma), [MONDO:0002210](http://purl.obolibrary.org/obo/MONDO_0002210) (vulva squamous cell carcinoma), [MONDO:0004232](http://purl.obolibrary.org/obo/MONDO_0004232) (large cell keratinizing variant squamous cell breast carcinoma), [MONDO:0004199](http://purl.obolibrary.org/obo/MONDO_0004199) (vulvar keratinizing squamous cell carcinoma), [MONDO:0006134](http://purl.obolibrary.org/obo/MONDO_0006134) (cervical adenosquamous carcinoma), [MONDO:0004231](http://purl.obolibrary.org/obo/MONDO_0004231) (spindle cell variant squamous cell breast carcinoma), [MONDO:0004196](http://purl.obolibrary.org/obo/MONDO_0004196) (rectal sarcomatoid carcinoma), [MONDO:0006490](http://purl.obolibrary.org/obo/MONDO_0006490) (vaginal squamous cell carcinoma), [MONDO:0018515](http://purl.obolibrary.org/obo/MONDO_0018515) (squamous cell carcinoma of rectum), [MONDO:0018513](http://purl.obolibrary.org/obo/MONDO_0018513) (squamous cell carcinoma of colon), [MONDO:0001419](http://purl.obolibrary.org/obo/MONDO_0001419) (trachea squamous cell carcinoma), [MONDO:0001779](http://purl.obolibrary.org/obo/MONDO_0001779) (vaginal squamous papilloma), [MONDO:0018352](http://purl.obolibrary.org/obo/MONDO_0018352) (squamous cell carcinoma of penis), [MONDO:0003714](http://purl.obolibrary.org/obo/MONDO_0003714) (bladder urachal squamous cell carcinoma), [MONDO:0003558](http://purl.obolibrary.org/obo/MONDO_0003558) (adenosquamous prostate carcinoma), [MONDO:0003556](http://purl.obolibrary.org/obo/MONDO_0003556) (endometrial adenosquamous carcinoma), [MONDO:0004129](http://purl.obolibrary.org/obo/MONDO_0004129) (cloacogenic carcinoma), [MONDO:0005614](http://purl.obolibrary.org/obo/MONDO_0005614) (pancreatic adenosquamous carcinoma), [MONDO:0003554](http://purl.obolibrary.org/obo/MONDO_0003554) (adenosquamous colon carcinoma), [MONDO:0004523](http://purl.obolibrary.org/obo/MONDO_0004523) (clear cell squamous cell skin carcinoma), [MONDO:0003555](http://purl.obolibrary.org/obo/MONDO_0003555) (Bartholin's gland adenosquamous carcinoma), [MONDO:0006303](http://purl.obolibrary.org/obo/MONDO_0006303) (middle ear squamous cell carcinoma), [MONDO:0003553](http://purl.obolibrary.org/obo/MONDO_0003553) (ampulla of vater adenosquamous carcinoma), [MONDO:0001651](http://purl.obolibrary.org/obo/MONDO_0001651) (scrotum squamous cell carcinoma), [MONDO:0004089](http://purl.obolibrary.org/obo/MONDO_0004089) (penis basaloid carcinoma), [MONDO:0003550](http://purl.obolibrary.org/obo/MONDO_0003550) (esophageal adenosquamous carcinoma), [MONDO:0003551](http://purl.obolibrary.org/obo/MONDO_0003551) (thymus adenosquamous carcinoma), [MONDO:0004087](http://purl.obolibrary.org/obo/MONDO_0004087) (basaloid lung carcinoma), [MONDO:0005056](http://purl.obolibrary.org/obo/MONDO_0005056) (keratinizing squamous cell carcinoma), [MONDO:0004088](http://purl.obolibrary.org/obo/MONDO_0004088) (cervical basaloid squamous cell carcinoma), [MONDO:0006143](http://purl.obolibrary.org/obo/MONDO_0006143) (cervical squamous cell carcinoma), [MONDO:0006385](http://purl.obolibrary.org/obo/MONDO_0006385) (primary intraosseous squamous cell carcinoma), [MONDO:0004080](http://purl.obolibrary.org/obo/MONDO_0004080) (glottis squamous cell carcinoma), 

**Mapped go classes:** [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0021955](http://purl.obolibrary.org/obo/GO_0021955) (central nervous system neuron axonogenesis), [GO:0006325](http://purl.obolibrary.org/obo/GO_0006325) (chromatin organization), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0008625](http://purl.obolibrary.org/obo/GO_0008625) (extrinsic apoptotic signaling pathway via death domain receptors), [GO:0046855](http://purl.obolibrary.org/obo/GO_0046855) (inositol phosphate dephosphorylation), [GO:0046856](http://purl.obolibrary.org/obo/GO_0046856) (phosphatidylinositol dephosphorylation), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0044320](http://purl.obolibrary.org/obo/GO_0044320) (cellular response to leptin stimulus), [GO:0043197](http://purl.obolibrary.org/obo/GO_0043197) (dendritic spine), [GO:0071257](http://purl.obolibrary.org/obo/GO_0071257) (cellular response to electrical stimulus), [GO:0051800](http://purl.obolibrary.org/obo/GO_0051800) (phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging), [GO:0032286](http://purl.obolibrary.org/obo/GO_0032286) (central nervous system myelin maintenance), [GO:0060074](http://purl.obolibrary.org/obo/GO_0060074) (synapse maturation), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:1990381](http://purl.obolibrary.org/obo/GO_1990381) (ubiquitin-specific protease binding), [GO:0046621](http://purl.obolibrary.org/obo/GO_0046621) (negative regulation of organ growth), [GO:2000808](http://purl.obolibrary.org/obo/GO_2000808) (negative regulation of synaptic vesicle clustering), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0021542](http://purl.obolibrary.org/obo/GO_0021542) (dentate gyrus development), [GO:0060997](http://purl.obolibrary.org/obo/GO_0060997) (dendritic spine morphogenesis), [GO:0071361](http://purl.obolibrary.org/obo/GO_0071361) (cellular response to ethanol), [GO:0051895](http://purl.obolibrary.org/obo/GO_0051895) (negative regulation of focal adhesion assembly), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0051896](http://purl.obolibrary.org/obo/GO_0051896) (regulation of protein kinase B signaling), [GO:0007416](http://purl.obolibrary.org/obo/GO_0007416) (synapse assembly), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0006606](http://purl.obolibrary.org/obo/GO_0006606) (protein import into nucleus), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0010666](http://purl.obolibrary.org/obo/GO_0010666) (positive regulation of cardiac muscle cell apoptotic process), [GO:0010941](http://purl.obolibrary.org/obo/GO_0010941) (regulation of cell death), [GO:0016242](http://purl.obolibrary.org/obo/GO_0016242) (negative regulation of macroautophagy), [GO:0030534](http://purl.obolibrary.org/obo/GO_0030534) (adult behavior), [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration), [GO:0051898](http://purl.obolibrary.org/obo/GO_0051898) (negative regulation of protein kinase B signaling), [GO:0060024](http://purl.obolibrary.org/obo/GO_0060024) (rhythmic synaptic transmission), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0097191](http://purl.obolibrary.org/obo/GO_0097191) (extrinsic apoptotic signaling pathway), [GO:0061515](http://purl.obolibrary.org/obo/GO_0061515) (myeloid cell development), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0097190](http://purl.obolibrary.org/obo/GO_0097190) (apoptotic signaling pathway), [GO:0090394](http://purl.obolibrary.org/obo/GO_0090394) (negative regulation of excitatory postsynaptic potential), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:0042711](http://purl.obolibrary.org/obo/GO_0042711) (maternal behavior), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0043491](http://purl.obolibrary.org/obo/GO_0043491) (protein kinase B signaling), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0097105](http://purl.obolibrary.org/obo/GO_0097105) (presynaptic membrane assembly), [GO:0045792](http://purl.obolibrary.org/obo/GO_0045792) (negative regulation of cell size), [GO:0097107](http://purl.obolibrary.org/obo/GO_0097107) (postsynaptic density assembly), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0010997](http://purl.obolibrary.org/obo/GO_0010997) (anaphase-promoting complex binding), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0051548](http://purl.obolibrary.org/obo/GO_0051548) (negative regulation of keratinocyte migration), [GO:0016479](http://purl.obolibrary.org/obo/GO_0016479) (negative regulation of transcription by RNA polymerase I), [GO:0061188](http://purl.obolibrary.org/obo/GO_0061188) (negative regulation of chromatin silencing at rDNA), [GO:0060134](http://purl.obolibrary.org/obo/GO_0060134) (prepulse inhibition), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0031174](http://purl.obolibrary.org/obo/GO_0031174) (lifelong otolith mineralization), [GO:0031175](http://purl.obolibrary.org/obo/GO_0031175) (neuron projection development), [GO:0061186](http://purl.obolibrary.org/obo/GO_0061186) (negative regulation of chromatin silencing at silent mating-type cassette), [GO:2000272](http://purl.obolibrary.org/obo/GO_2000272) (negative regulation of receptor activity), [GO:0036462](http://purl.obolibrary.org/obo/GO_0036462) (TRAIL-activated apoptotic signaling pathway), [GO:1901017](http://purl.obolibrary.org/obo/GO_1901017) (negative regulation of potassium ion transmembrane transporter activity), [GO:0004402](http://purl.obolibrary.org/obo/GO_0004402) (histone acetyltransferase activity), [GO:0070210](http://purl.obolibrary.org/obo/GO_0070210) (Rpd3L-Expanded complex), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:1990314](http://purl.obolibrary.org/obo/GO_1990314) (cellular response to insulin-like growth factor stimulus), [GO:0001933](http://purl.obolibrary.org/obo/GO_0001933) (negative regulation of protein phosphorylation), [GO:0002902](http://purl.obolibrary.org/obo/GO_0002902) (regulation of B cell apoptotic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0051717](http://purl.obolibrary.org/obo/GO_0051717) (inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0032535](http://purl.obolibrary.org/obo/GO_0032535) (regulation of cellular component size), [GO:0030476](http://purl.obolibrary.org/obo/GO_0030476) (ascospore wall assembly), [GO:2001235](http://purl.obolibrary.org/obo/GO_2001235) (positive regulation of apoptotic signaling pathway), [GO:0060044](http://purl.obolibrary.org/obo/GO_0060044) (negative regulation of cardiac muscle cell proliferation), [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0036294](http://purl.obolibrary.org/obo/GO_0036294) (cellular response to decreased oxygen levels), [GO:0005031](http://purl.obolibrary.org/obo/GO_0005031) (tumor necrosis factor-activated receptor activity), [GO:0048679](http://purl.obolibrary.org/obo/GO_0048679) (regulation of axon regeneration), [GO:0043542](http://purl.obolibrary.org/obo/GO_0043542) (endothelial cell migration), [GO:0007613](http://purl.obolibrary.org/obo/GO_0007613) (memory), [GO:0042577](http://purl.obolibrary.org/obo/GO_0042577) (lipid phosphatase activity), [GO:0007611](http://purl.obolibrary.org/obo/GO_0007611) (learning or memory), [GO:0045569](http://purl.obolibrary.org/obo/GO_0045569) (TRAIL binding), [GO:0048681](http://purl.obolibrary.org/obo/GO_0048681) (negative regulation of axon regeneration), [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0033698](http://purl.obolibrary.org/obo/GO_0033698) (Rpd3L complex), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0060291](http://purl.obolibrary.org/obo/GO_0060291) (long-term synaptic potentiation), [GO:0010975](http://purl.obolibrary.org/obo/GO_0010975) (regulation of neuron projection development), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0060292](http://purl.obolibrary.org/obo/GO_0060292) (long term synaptic depression), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0061002](http://purl.obolibrary.org/obo/GO_0061002) (negative regulation of dendritic spine morphogenesis), [GO:1903690](http://purl.obolibrary.org/obo/GO_1903690) (negative regulation of wound healing, spreading of epidermal cells), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:1904668](http://purl.obolibrary.org/obo/GO_1904668) (positive regulation of ubiquitin protein ligase activity), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0061408](http://purl.obolibrary.org/obo/GO_0061408) (positive regulation of transcription from RNA polymerase II promoter in response to heat stress), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0035749](http://purl.obolibrary.org/obo/GO_0035749) (myelin sheath adaxonal region), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0050765](http://purl.obolibrary.org/obo/GO_0050765) (negative regulation of phagocytosis), [GO:0060341](http://purl.obolibrary.org/obo/GO_0060341) (regulation of cellular localization), [GO:0007270](http://purl.obolibrary.org/obo/GO_0007270) (neuron-neuron synaptic transmission), [GO:2000060](http://purl.obolibrary.org/obo/GO_2000060) (positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0035064](http://purl.obolibrary.org/obo/GO_0035064) (methylated histone binding), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0000118](http://purl.obolibrary.org/obo/GO_0000118) (histone deacetylase complex), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:1903984](http://purl.obolibrary.org/obo/GO_1903984) (positive regulation of TRAIL-activated apoptotic signaling pathway), [GO:0048854](http://purl.obolibrary.org/obo/GO_0048854) (brain morphogenesis), [GO:0048853](http://purl.obolibrary.org/obo/GO_0048853) (forebrain morphogenesis), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0090071](http://purl.obolibrary.org/obo/GO_0090071) (negative regulation of ribosome biogenesis), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:2000219](http://purl.obolibrary.org/obo/GO_2000219) (positive regulation of invasive growth in response to glucose limitation), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0004438](http://purl.obolibrary.org/obo/GO_0004438) (phosphatidylinositol-3-phosphatase activity), [GO:0050771](http://purl.obolibrary.org/obo/GO_0050771) (negative regulation of axonogenesis), [GO:0010719](http://purl.obolibrary.org/obo/GO_0010719) (negative regulation of epithelial to mesenchymal transition), [GO:0031658](http://purl.obolibrary.org/obo/GO_0031658) (negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0031939](http://purl.obolibrary.org/obo/GO_0031939) (negative regulation of chromatin silencing at telomere), [GO:0045475](http://purl.obolibrary.org/obo/GO_0045475) (locomotor rhythm), [GO:0033555](http://purl.obolibrary.org/obo/GO_0033555) (multicellular organismal response to stress), [GO:0030165](http://purl.obolibrary.org/obo/GO_0030165) (PDZ domain binding), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0035335](http://purl.obolibrary.org/obo/GO_0035335) (peptidyl-tyrosine dephosphorylation), [GO:0032228](http://purl.obolibrary.org/obo/GO_0032228) (regulation of synaptic transmission, GABAergic), [GO:0016314](http://purl.obolibrary.org/obo/GO_0016314) (phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity), [GO:0035176](http://purl.obolibrary.org/obo/GO_0035176) (social behavior), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0060179](http://purl.obolibrary.org/obo/GO_0060179) (male mating behavior), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0033032](http://purl.obolibrary.org/obo/GO_0033032) (regulation of myeloid cell apoptotic process), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0060736](http://purl.obolibrary.org/obo/GO_0060736) (prostate gland growth), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0002275](http://purl.obolibrary.org/obo/GO_0002275) (myeloid cell activation involved in immune response), [GO:0008656](http://purl.obolibrary.org/obo/GO_0008656) (cysteine-type endopeptidase activator activity involved in apoptotic process), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0008138](http://purl.obolibrary.org/obo/GO_0008138) (protein tyrosine/serine/threonine phosphatase activity), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0004722](http://purl.obolibrary.org/obo/GO_0004722) (protein serine/threonine phosphatase activity), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0043220](http://purl.obolibrary.org/obo/GO_0043220) (Schmidt-Lanterman incisure), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0070373](http://purl.obolibrary.org/obo/GO_0070373) (negative regulation of ERK1 and ERK2 cascade), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:2001159](http://purl.obolibrary.org/obo/GO_2001159) (regulation of protein localization by the Cvt pathway), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:2000463](http://purl.obolibrary.org/obo/GO_2000463) (positive regulation of excitatory postsynaptic potential), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), [GO:0031642](http://purl.obolibrary.org/obo/GO_0031642) (negative regulation of myelination), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 55.31%
- [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia) 50.72%
- [GO:0071257](http://purl.obolibrary.org/obo/GO_0071257) (cellular response to electrical stimulus) 50.72%
- [GO:0061408](http://purl.obolibrary.org/obo/GO_0061408) (positive regulation of transcription from RNA polymerase II promoter in response to heat stress) 50.72%
- [GO:0060746](http://purl.obolibrary.org/obo/GO_0060746) (parental behavior) 50.72%
- [GO:0051602](http://purl.obolibrary.org/obo/GO_0051602) (response to electrical stimulus) 50.72%
- [GO:0045475](http://purl.obolibrary.org/obo/GO_0045475) (locomotor rhythm) 50.72%
- [GO:0042711](http://purl.obolibrary.org/obo/GO_0042711) (maternal behavior) 50.72%
- [GO:0035176](http://purl.obolibrary.org/obo/GO_0035176) (social behavior) 50.72%
- [GO:0007270](http://purl.obolibrary.org/obo/GO_0007270) (neuron-neuron synaptic transmission) 50.72%
- [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia) 50.72%
- [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat) and [GO:2001141](http://purl.obolibrary.org/obo/GO_2001141) (regulation of RNA biosynthetic process) 50.72%
- [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat) and [GO:2000112](http://purl.obolibrary.org/obo/GO_2000112) (regulation of cellular macromolecule biosynthetic process) 50.72%
- [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat) and [GO:1903508](http://purl.obolibrary.org/obo/GO_1903508) (positive regulation of nucleic acid-templated transcription) 50.72%
- [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat) and [GO:1903506](http://purl.obolibrary.org/obo/GO_1903506) (regulation of nucleic acid-templated transcription) 50.72%


